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The Marine Biotechnology ERA-NET  
(ERA-MBT) is a consortium of 19 national 
funding agencies seeking complementarities 
between national activities by pooling resources 
to undertake joint funding of transnational 
projects in the area of Marine Biotechnology.  
 
During the lifetime of the project the following 
activities will be carried out, supporting the 
European Bioeconomy:  
 
• Launching three thematic calls to 
generate joint European research and 
development activities. 
• Arranging a number of stakeholder 
events to promote dialogue between 
science, industry and policy and to 
identify requirements for successful 
developments within the area. 
• Performing outreach activities to seek 
complementarities and avoid overlap 
with other activities sharing common 
interest with ERA-MBT. 
• Establishing a Strategic Roadmap with 
the support of the International 
Advisory Group, an expert panel 
reflecting views and expertise from the 
scientific, policy and business sectors. 
• Developing a perspective on the future 
of marine biotechnology research and 
development and its likely impacts. 
• Providing information about marine 
biotechnology in an online and open 
access portal with a wiki function. 
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EDITORIAL 
 
Marine Biotechnology in the Bioeconomy 
 
Environmental concerns, economic realities and nature's role in 
supporting our lives, have brought political attention to the need for 
changes to how society can be sustainably supported. Goods, 
services, food and welfare are mainly taken for granted in Europe, 
but as fossil oil resources are declining, the term Bioeconomy has 
come on the agenda. Conferences, reports, research and innovations 
are devoted to understand and develop how to create a future where 
it is the resources in the biomasses that support our lives. This is 
basically the core of the bioeconomy.  
 
To manage this change, new knowledge and new innovations needs 
to be realized related to how biomass of all kinds, sustainably and 
resource efficiently can be transformed into food, feed, chemicals, 
energy, etc… 
… continued on page 2 
ERA-MBT Consortium at the project management meeting in Ljubljana, Slovenia,  
22 April 2015 
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FIRST JOINT CALL  
 
Through the first joint call entitled “The 
development of biorefinery processes for marine 
biomaterials”, 14 funding organisations from 11 
countries brought together almost 9M€ to support 
transnational research projects from academia and 
industry.  
After the submission deadline in December 2014, 
the call secretariat received 37 pre-proposals, with a 
requested funding of 42 M€ and own contribution of 
10 M€. Industry participated with 42 partners in the 
various projects. The pre-proposals were clustered 
into five main marine biomass groups: Bacteria or 
other non-algae microorganisms (10), Microalgae 
(9), Macroalgae (6), Fish (7) and 
Crustacea/Molluscs/Others(5). 
All pre-proposals were reviewed and classified by at 
least 3 different experts, over a period of three 
months. In February 2015 and based on the experts’ 
classifications, the Call Steering committee (CSC) 
members decided on the threshold for selecting 
projects to be invited to send full proposals. Out of 
the 35 eligible pre-proposals, 24 (~30 M€) were  
selected and invited to submit a full proposal before 
30 April 2015. This left a significant number of 
promising proposals on the contest which were 
evaluated by the final Expert Panel Meeting in June 
2015.  
The Call Steering Committee is expected to reach a 
final funding decision before the end of July. 
 
 
Follow the website for more news: 
http://www.marinebiotech.eu/first-transnational-call 
 
 
 
 
 
 
 
Steinar Bergseth 
The Research Council of Norway (RCN), 
Norway 
 
 
Land based biomass, most often as wood and (by) products from 
agriculture, have for historical and natural reasons been in focus until now, 
and multistream biorefineries able to handle the processing of cellulosic 
feedstock into a range of products are emerging. A significant challenge is 
to develop processes that are cost efficient enough to meet a market where 
the fossil oil derived products rule. Another challenge is to produce 
enough of all the different goods a society needs and someday be able to 
sustainably deliver products based on nature's renewable resources.  
 
In this context, the marine environment which makes up more than 70 % 
of the planet's surface must come into play as a significant resource for the 
supply of carbons embedded in proteins, fats and cellulose fractions. 
Luckily enough, the marine polysaccharides have structures easier to 
utilize than terrestrial ones, and marine fats have different beneficial 
health effects from terrestrial ones, just to mention a few of the many 
obvious arguments to forcefully include the marine environment as a 
natural part of the foundation for the bioeconomy. Through a strategic 
focus on the possibilities for also the marine environment to deliver, 
society will be much better off when being supported with a supply of a 
future scarce feedstock. 
 
To utilise the marine biomasses, biotechnological knowledge and methods 
needs to be developed and adapted for the specificities of this 
environment. ERA-MBT's role is to help fill the biotechnological toolbox 
and coordinate transnational financial and strategic resources to stimulate 
a development leading to sustainable utilization of marine biomass and its 
contribution to foster the European bioeconomy. 
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Download documents: 
 Programme 
 Participants list 
 Presentations 
 News report 
 Public report 
 Photo gallery 
 
THE VOICE OF  
A STAKEHOLDER 
 
 
An important role of the ERA-MBT is to have dialogue with its 
stakeholders. In conversation with Mr Jens Bleiel the Chief Executive 
of Food for Health Ireland
1
 (FHI), Dr Dermot Hurst from Ireland’s 
Marine Institute explored the search for new food ingredients by FHI 
and discussed the role of marine origin compounds as functional food 
ingredients. Ireland is a leading supplier of food ingredients to Europe 
and the rest of the world. A strong tradition in dairy processing 
initially led to Irish firms producing worlds famous dairy products, 
after which firms in the dairy sector started to “mine” milk in the 
search for new sources of healthy food ingredients. FHI is a joint 
venture between Irish public research institutions and leading Irish 
Dairy companies to identify novel ingredients for use in food products 
and dietary supplements. This distributed research centre is supported 
by investments from industry and the state that will total €40 million 
by 2018.  
 
Q: What level of awareness exists in the global food sector of 
the potential of marine bioactives as functional ingredients? 
 
A: A key feature of the food sector is the constant attention given to 
product and process innovation. This includes an ongoing search by 
firms for materials with the potential to improve the health benefits of 
food products and to improve their competitiveness. It is not only the 
growth in the global markets for healthy foods that is behind this 
innovation, but also the need to provide the food matrix with 
enhanced functionality during processing and production; in storage; 
and in use or consumption by the customer or end user. And 
importantly to meet demands from customers for natural ingredients. 
While few firms would have a specific demand for marine bioactives; 
they all have a high level of awareness of the role and potential of all 
naturally sourced materials – be that plant or animal, bioactive or 
passive. More important for the food firm than the origin of a natural 
ingredient when looking for new compounds, is the fit with key 
acceptance criteria including, the functionality of the ingredient; that 
it is safe to use; its taste properties; cost effectiveness and whether it 
can be scaled up from laboratory to production levels. The challenge 
of ensuring a sustainable supply of ingredients often means firms 
develop more than a single source of supply.  
 
Q: What market and other factors are driving the search for 
novel functional ingredients in the food sector? 
 
A: Functional foods, are whole foods or food components that may 
provide the consumer with demonstrated physiological benefits or 
reduce the risk of chronic diseases, in addition to providing basic 
nutritional functions. What we choose to eat can have a profound 
Jens Bleiel 
Chief Executive of FHI 
 
FIRST ERA-MBT 
STAKEHOLDER 
MEETING REPORT IS 
ONLINE! 
 
Topic? WAVES OF INNOVATION - 
Integrating National Efforts to Build the 
Future of Marine Biotechnology 
 
When? 28th - 29th October 2014 
 
Stakeholder feedback? The stakeholder 
event was considered as highly successful in 
addressing strategic issues that will be taken 
into account for further developing ERA-
MBT and providing participants with the 
opportunity to expand their research and 
other collaborative networks. 
The report outlines extensive stakeholder 
feedback. 
 
 
 
 
 
 
 
 
 
Photocredit: VLIZ 
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effect on body function. Research consistently shows the links between 
diet and health. The promotional efforts of health authorities in 
highlighting this, has influenced consumer food choice. In seeking new 
ingredients, the food industry is responding to pressures from authorities 
and consumers for food products that contribute to health and lifestyle. 
Competition within the food sector to find health beneficial components 
is strong and rising. Being able to attach a health claim to a natural 
origin compound gives a massive competitive edge to a firm producing 
food ingredients. 
 
Q: Are there signs of a merging of food and pharma 
products/firms with the obvious search for novel health 
compounds? 
 
A: There are similarities but as yet the signs are insufficient to support 
any claim of a merging of interests or markets. An essential difference is 
the pharmaceutical sector produces products to help people to get better 
and recover from illness, whereas the challenge for food ingredients 
firms remains clearly focused on helping to prevent food related 
illnesses by producing tasteful and enjoyable nutrition. Each sector has 
different regulatory systems; developing a new drug typically takes 
upwards of 15 or even 20 years, whilst a qualifying a new functional 
ingredient and registering a health claim might take less than ten years. 
However, there are some noticeable similarities in each sector. The 
R&D tool box used by food and pharma has evolved around common 
core scientific disciples; the use of certain analytical or “omics” 
technologies is common in both and there are similarities in aspects of 
product safety and production processes. The emphasis on scientific and 
technological development in each creates opportunities for technology 
transfer and possibly achieving economic synergies. The food industry 
is more and more adopting the Pharma “tool box” for its high end 
research and I would envisage that both sectors will continue to add to 
the range of available research tools. 
 
Q: From a purely functional perspective, what compounds are 
high on the research agenda in the search for new food 
ingredients? 
 
A: Rather than specific compounds or sources, and there are many that 
are under investigation, the research emphasis is on finding food 
solutions that contribute to improving health. High on the target list for 
functional foods/ingredients are metabolic health, the prevention of 
diabetes, obesity, aging, cardio-vascular health, muscle health, weight 
management and customized nutrition - particularly sports nutrition and 
low GI (Glycemic Index) foods. At FHI we are building on our 
knowledge of milk proteins and comparing proteins from other natural 
sources. Because our scientific capabilities evolved from early work on 
natural products from milk, we have established benchmarks that allow 
us to investigate a wide range of other natural compounds and to screen 
them using a wide range of bioassays that help us to assess their effect 
on improving health. High on the list of research priorities are also 
studies of the role of lipids and oligosaccharides in early life. Research 
into polysaccharides (especially fucoidan) is a rapidly emerging 
research area. Interestingly, from the perspective of the ERA-MBT 
project, the marine environment is a source of lipids and 
polysaccharides. 
 
 
 
 
 
 
 
 
SHORT BIOGRAPHY: 
JENS BLEIEL 
Jens Bleiel started his career at a management consultant 
company in Germany. After 5 years, he joined Dutch 
company Numico and held several management and 
executive functions in the baby food branch of the 
company. His last function was Global Marketing 
Director Infant Milks. After 10 years in this business, 
Jens Bleiel joined Dutch multinational DSM. As Senior 
Vice President Metabolic Health Products, he built up 
the functional food business in the area of metabolic 
health products. In August 2009, Jens Bleiel was 
appointed as Chief Executive Officer of Food for Health 
Ireland and moved over to Ireland. Food for Health 
Ireland combines world-class science of 7 Public 
Research Organisations and the industry expertise of 5 
leading dairy companies in Ireland to improve health 
through innovation in food. 
  Photocredit: Cushla Dromgool-Regan; Copyright: Marine Institute 
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Q: What contributions to the global food sector do you think 
marine origin functional ingredients could make? 
 
A: An immediate advantage of a marine origin ingredient is that it is 
formed from a natural source(s) which is an important entry criteria for 
industry. But alone this is insufficient to them to make an impact in the 
food sector; they also have to meet the rigid specification for safety, 
efficacy, taste, cost, consistency of supply and scaleability. Compared to 
the terrestrial environment, we have yet to fully understand the potential 
of the marine environment as a source of functional ingredients. We are, 
however, aware of the immense environmental diversity within the 
oceans and with it the potential it offers as a source of biological and 
chemical diversity. The food industry welcomes if this diversity can 
provide new ingredients that offer high potency, improved functionality 
and would ideally be available at a lower cost than current ingredients. 
Sustainability of supply and environmental sustainability are hugely 
important for the food sector, marine products need to meet industry 
requirements on both fronts.  
 
 
Q: Do you think scope exists to strengthen links between 
researchers involved in marine biotechnology related areas and 
the food ingredients sector?  
 
A: Yes, there are always opportunities to strengthen collaboration, be it 
between researchers, or between industry and the research community. 
We would like to see further progress on developing new multi-
disciplinary collaboration on research that also includes an increased 
involvement with customers, funding agencies and with the regulatory 
authorities. We are beginning to increase our efforts to better understand 
the health effects of combining ingredients and to develop insights to the 
various mechanisms that are involved in complex interactions. There is 
some evidence that points to a possible link between the role of β-
glucans in maintaining normal blood cholesterol concentrations and in 
maintaining or achieving a normal body weight. And we know that some 
dairy protein-derived amino acids can enhance muscle protein synthesis, 
lean body mass and skeletal muscle metabolic function. We are therefore 
starting to consider the effect of combining marine and dairy origin 
ingredients for enhanced functionality.. Though we are in the early 
stages of this work, we certainly recognise the potential in continuing 
this kind of work, making the promise of the marine to providing more 
and more novel ingredients especially exciting. Ireland has a dedicated 
research programme (NutraMara) which investigates marine functional 
foods, and FHI has strong links with NutraMara that allows us to directly 
compare the performance of marine functional ingredients with dairy 
ingredients; it is early days yet but we anticipate being able to share 
some interesting insights from this work in the near future..  
 
 
1 Established in 2008,  Food for Health Ireland (FHI) is one of the biggest 
technology centres in Ireland and its purpose is to identify novel ingredients 
coming from milk to develop functional food ingredients which will offer health 
benefits to consumers. The research is focusing on infant nutrition, healthy 
cheese, appetite modulation, performance nutrition and healthy ageing as well as 
products that can be used to manage elevated glucose levels. For more 
information about FHI see http://www.fhi.ie. 
ERA-MBT IN 
INTERNATIONAL 
EVENTS 
 
 
BIOPROSP_15 CONFERENCE 
 
BIOPROSP International Conference on Marine 
Bioprospecting is a biennial conference on 
bioprospecting from cold marine environment that 
is held in the university town of Tromsø in 
Northern Norway. The conference has been 
organized since 2002 and it has already established 
itself as one of best conferences in the field of 
marine bioprospecting. The 7th BIOPROSP 
conference was held from February 18-20, 2015 
and focused on the possibilities and challenges in 
industrial development of novel marine bioactive 
compounds and biomass.  
About 200 stakeholders in biotech life sciences 
and pharmaceutical industry, scientists, public 
support system, decision-makers and others 
interested in marine bioprospecting and 
biotechnology attended the conference, including 
some of the ERA-MBT partners.  
The BIOPROSP_15 conference brought together 
scientists and industry representatives and 
addressed issues of how to translate basic research 
into applied research on possible industrial 
applications– overcoming the bottlenecks. Leading 
speakers from science and industry gave updates 
on what's new and what's next within the field of 
biodiscovery. 
More information at http://bioprosp.com/about 
 
 
 
 
Photocredit: BIOPROSP_15 
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Photocredit: Rendez-Vous de Concarneau 2014 
  
 
NATIONAL MARINE BIOTECH 
RELEVANT NEWS 
ITALY       
• Two principal strategies have been planned regarding the Blue 
Growth at regional level “The Smart Specialisation Strategy – RIS3 
Sicilian Region” and at national level the “Italian Consultation 
Board scoping paper SC2 Horizon 2020 Societal Challenge“. The 
Italian Forum for Industrial Biotechnology (IFIB) is an interesting 
meeting promoting the starting collaborations between academy, 
industries, public and private stakeholders.  
 
• The Intesa Sanpaolo Startup Initiative is an international 
acceleration platform which selects promising high-tech startups, 
coaches them and connects them with financial and corporate 
investors. A call for companies, start-ups and projects focusing on 
Red Biotech (e.g. life sciences, diagnostics, drug discovery, drug 
delivery, therapy and treatment) and Green & White Biotech (e.g. 
biotech for environment and agriculture, biomaterials and biofuels, 
marine biotech) has just been closed. A recap and the downloadable 
documents can be found on the website. 
 
• An education project: POR-FSE 2007-13 Progetto CIP n. 19 
“Eco.mar” Education: Strengthening of R&S system and creation of 
new Spin-Off in the frame of the Blue Growth (2015).  
 
 
 
NEW CALEDONIA (NC) &    
EUROPEAN OVERSEAS COUNTRIES  
AND TERRITORIES (OCTS) 
    
• The new AOD, (Overseas association decision) that draw up the 
framework of relations (EU) and Overseas Countries and Territories 
(OCTs), entered into force in 2014. It establishes a more reciprocal 
partnership, centered of competitiveness and regional integration. 
 
• In 2014, the project “Territorial Strategies for Innovation (TSI)“ 
funded by EU and coordinated by OCTA started. The project is built 
on a proposition made by New Caledonia. Each OCT will foster 
cooperation between key stakeholders (research, industry, and public 
institution), aiming to set up territorial strategies for innovation, 
building on OCTs’ capacities and comparative assets. For French 
OCT in the Pacific, like New Caledonia or French Polynesia, for 
which Marine Biotech have already been identified as priority even 
if there is no formal dedicated strategy, it will speed up the process 
and precise the place of Marine Biotechnology for territorial 
innovation.  
CONCARNEAU MEETINGS 
 
A series of conferences have been held with the 
title ’Rendez-Vouz de Concarneau – Where 
Industry Meets Science in Marine 
Biotechnology’. The venue is always the 
Biological Station in Concarneau, Bretagne. In 
the period when ERA-MBT was prepared, i.e. 
under the CSA MarineBiotech, several members 
of the consortium made presentations and gave 
an update on how the planning of the ERA-MBT 
proceeded. 
2014. At the meeting of 9-10 October 2014,  
Catherine Boyen, CNRS, France, gave a 
presentation on ‘Progress in ERA-NET 
MarineBiotech with particular focus on French 
participation’. After giving an overview of ERA-
MBT and the different actions, she gave 
examples of ongoing projects in France within 
the area of marine biotechnology, and how the 
collaboration between research and industry was 
organised. In the same session, Renata Denaro at 
Institute for Coastal Marine Environment – 
National Research Council, Italy, presented the 
‘Industry-policy interactions as targeted in the 
ERA-NET MarineBiotech’. She gave a good 
overview of the industry-oriented activities in 
ERA-MBT (WP3) and presented the initial 
results of a mapping survey of the marine 
biotechnology environment in Europe with 
emphasis on the industry sector, its use of raw 
materials and the products marketed.  
Download here the full report on ‘ERA-MBT 
Open Stakeholder Consultation’. 
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2015. The Concarneau meeting this year is 
scheduled to take place 15-16 October, and 
members of the ERA-MBT will again be present. In 
the morning session the first day, focus will be on 
Access and Benefit Sharing (ABS) of genetic 
resources found in the marine environment, where 
Catherine Boyen, CNRS, Roscoff, France will be 
one of the moderators. In the afternoon session, 
focus will be on marine biotechnology and SMEs. 
ERA-MBT Coordinator Steinar Bergseth, RCN, will 
give an ‘Overview of marine biotechnology SMEs 
in Europe’, followed by presentations from different 
companies and organisations in Europe. The last day 
of the conference will be devoted to marine 
biotechnology in Polynesia. 
 
ERA-MBT AT A MAJOR IRISH 
CONFERENCE – NUTRAMARA 
NutraMara - the Marine Functional Foods Research 
Initiative - is a research programme for marine 
based functional food development which focuses 
on the mining of marine bioresources including 
seaweeds (macroalgae), microalgae and marine 
processing by-products as well as aquaculture, for 
functional food ingredients. On 29-30th June 2015 a 
Conference and Expo was hosted at the Royal 
Dublin Society, gathering more than 200 
participants, where the latest international scientific 
findings in harnessing and exploiting marine 
bioresources were presented. 
At the opening session, ERA-MBT Deputy 
Coordinator Torger Børresen gave an overview on 
‘Innovation in the European marine bioresources 
sector’. At the second day of the conference IAG 
member of ERA-MBT, Professor Alan Dobson gave 
a presentation on ‘Marine bacteria as a source of 
novel bioactive agents for use in strategies against 
foodborne pathogens and in food processing 
applications’. 
WP2 leader of ERA-MBT, Dermot Hurst, 
moderated a panel session where the questions were 
raised: what is the greatest challenges, and what are 
the most promising potentials when exploiting 
marine resources?  
 
 
 
 
 
 
• Early 2014, the Innovation Division of ADECAL-Technopole (NC) 
opened a business incubator to support innovative companies and 
projects bearers (topic: marine and terrestrial resources, renewable 
energy, TIC). 
 
• The French Ministry of Research and Higher Education (NC) has 
given the impulse to setup a consortium for cooperation of research 
at site scale, in order to increase synergies between research 
institutions and formalize local research assets and priorities. For 
New Caledonia, this consortium has been signed in Sept 2014 
(CRESICA). One of the topics is the enhancement of biodiversity 
and natural substance. 
  
• A Maritime Cluster was created in August 2014, gathering actors 
within the marine sector (32 members). The aim of the cluster is to 
advocate the role of the blue sector for the economy of NC, raise 
policy maker awareness and increase political attention and 
investment. 
 
 
 
 
 
NORWAY AND PORTUGAL  
STRENGTHEN COOPERATION 
 
• Norway and Portugal have signed an agreement for increased ocean 
related Scientific and Technological Cooperation, based on their 
mutual interest in strengthening research for sustainable 
management and utilization of marine resources. Portugal's 
President Silva visited the Research Council on 4 May 2015, on the 
occasion of the signing of the MOU on ocean related scientific and 
technological cooperation between the Research Council of Norway 
(RCN) and the Portuguese Research Council (FCT). He brought 
with him an entourage of nearly 100 people, including three 
ministers, representatives of management and research, and no less 
than 20 journalists. The agreements underline the strategic 
importance of the sea for growth and development in Europe. The 
signing ceremony was followed by a workshop on marine 
biotechnology and bioprospecting for scientists and business leaders 
from Portugal and Norway, held in cooperation with Innovation 
Norway and FCT. In addition, parallel sessions on seafood, marine 
environment and offshore energy and technology were arranged to 
provide researchers from both countries the opportunity to meet and 
discuss research.  
Photocredit: NutraMara Conference 2015 
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PORTUGAL     
• Portugal has a “National Ocean Strategy 2013-2020 (ENM)” which 
lists a series of concrete measures and actions in Marine 
Biotechnology. There are several public and private institutions and 
organisations that support this mission, like clusters (ocean XXI and 
blue alliance), dedicated publications (magazine and journals), 
entrepreneurship & innovation associations and specialized law 
firms. There are some private funding mechanisms but the main 
financial support comes from public funds, national and European.   
 
• Currently, calls from European structural funds are being launched 
through The European Maritime and Fisheries Fund (EMFF) 
(aquaculture and fisheries) but also through transversal programmes 
such as COMPETE, and other regional or thematic programmes.  
 
• National funds support marine biotech through the funding of 
institutions, research projects, infrastructures and scholarships. There 
are several R&D institutions with specialisation in MBT and 25 
large marine research facilities registered in the European large 
exchangeable instruments database.   
 
 
 
SPAIN      
• The Spanish strategy is developed under the leading authority of the 
Ministry of Economy and Competitiveness (MINECO) through the 
Secretariat of state for research, development and innovation. The 
strategy is implemented through the Spanish National Plan for 
Scientific and Technical Research and Innovation (PECTI) (2013-
2016), a document designed to develop and fund Central 
Government actions in the area of RDI. 
  
• These actions are set out in four National Programmes. The National 
Programme for RDI oriented to the Societal Challenges fosters the 
participation of Spanish research groups in international cooperative 
projects, through the International Joint Programming Actions. 
Although there is not a specific programme on “Marine 
Biotechnology”, the marine and maritime RTDI activities are 
included in the societal challenges “Food security, sustainable 
agriculture and forestry, marine and maritime and inland water 
research, and the Bioeconomy” and “Climate action, environment, 
resource efficiency and raw materials”. 
SYNERGIES WITH 
OTHER PROJECTS 
 
BG-14: ATLANTIC OCEAN 
RESEARCH ALLIANCE 
COORDINATION AND 
SUPPORT ACTION (AORAC-SA) 
 
 
 
The objective of the AORAC project is to provide 
scientific, technical and logistical support to the 
European Commission in developing and 
implementing trans-Atlantic Marine Research 
Cooperation between the European Union, the 
United States of America and Canada. The CSA is 
carried out within the framework of the Atlantic 
Ocean Research Alliance as outlined in the Galway 
Statement on Atlantic Ocean Cooperation (May 
2013).  
Recognising the evolving nature of the Atlantic 
Ocean Research Alliance, the hallmark of this 5year 
project  is that it is flexible, responsive, inclusive, 
efficient, innovative, value-adding and supportive. 
As such, the project will provide a platform to 
engage the widest European input, engaging with 
research policy makers and funders, research 
performers, major regional and pan-European 
research networks, and including industry and NGO 
interests.  
Marine Biotechnology is one of the six identified 
research priority areas for which a mapping and 
assessment exercise will be carried out to identify 
relevant industry needs and research gaps. This will 
contribute to aligning the planning and 
programming of future cooperative research 
activities. Sigurdur Bjornsson, Head of Science and 
Innovation at the Icelandic Centre for Research 
(Rannis) is leading the marine biotechnology related 
activities within the project and will closely involve 
the ERA-MBT partners in these developments.   
The AORAC website will be coming soon.  
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MARINE AND MARITIME 
KNOWLEDGE TRANSFER – 
EXPLORING BLUE GROWTH WITH 
COLUMBUS 
 
 
 
The COLUMBUS project, a flagship European Commission-
funded Blue Growth initiative, has successfully kicked-off and 
now moves into the first stages of managing knowledge and 
carrying-out Knowledge Transfer of marine research outputs to 
measurably increase their uptake and application by different end-
users, such as industry, policy makers, and society in general. 
COLUMBUS represents the most substantial investment by the 
EC in Knowledge Transfer to date. The EC has provided €4m 
funding for the three-year project, which is designed to ensure that 
outputs arising from publicly-funded marine research projects 
have positive societal benefit.  
 
COLUMBUS is very much at the forefront of the Blue Growth 
agenda, as its overarching objective is to ensure that applicable 
knowledge generated through EC-funded science and technology 
research can be transferred effectively to advance the governance 
of the marine and maritime sectors while improving 
competitiveness of European companies and unlocking the 
potential of the oceans to create future jobs and economic growth 
in Europe. 
COLUMBUS will establish a “Knowledge Fellowship”, a 
network of nine full-time Knowledge Transfer Fellows whose role 
will be to carry out Knowledge Transfer using a methodology 
based on the needs prioritised early in the project. These fellows 
will work across nine nodes, each with a specific focus area. 
Marine Biotechnology will be dealt with within the Marine 
Biological Resources Competence Node, which is overseen by 
CNRS – specifically the station biologique de roscoff. 
COLUMBUS is an ambitious project with the potential to deliver 
game-changing results. To be successful, the partnership will need 
to cooperate and collaborate. As such, the Marine Biotechnology 
ERA-NET is one of the projects that will be followed up and  
which output will be taken forward to help achieve measurable 
impacts and to develop a blueprint for future activities in this field 
of work, ultimately contributing to the development of a thriving 
and sustainable marine and maritime economy. 
The COLUMBUS website will be coming soon at 
www.columbusproject.eu.  
NEW PARTNERSHIPS AS  
ERA NET COFUNDS 
 
There is a new trend in supporting money from the 
Commission, now turning more funds into various 
partnerships. One category is termed COFUNDs, and 
the difference relative to the traditional ERA NETs is 
that the Commission adds funds to what is 
contributed by the different Member States in the 
call. This means that the traditional ERA NETs as we 
know them will not exist in the future. 
In ERA-MBT we have a task in WP2, where we will 
‘Develop a framework and initial cooperation for a 
sustainable, European marine biotechnology 
supportive network’ that will last also after the 
present ERA-MBT financial period. Although we 
have more than two years more to prepare such a 
lasting partnership, it is important to start early. It is 
thus if interest to observe which ERA NET 
COFUNDs are being called for in the 2016-17 period 
of Horizon 2020. 
The provisional call text scheduled to be launched in 
October 2015 contains two interesting topics that 
could be of considerable value for the future of ERA-
MBT. One topic ‘ERA NET COFUND on 
Biotechnologies’ is being planned as part of the work 
programme termed ‘Nanotechnologies, Advanced 
Materials, Biotechnology and Advanced 
Manufacturing and Processing’ (NMBP). This topic 
addresses three ERA NETs being ERA-IB, 
ERASynBio and ERASysAPP, but consortia 
applying for funds from the topic may just as well 
include partners not having participated in these ERA 
NETs, and the topic description may allow for 
contents that today is relevant also for ERA-MBT. 
The second topic for the next call of interest to 
marine biotechnology is nested under the Blue 
Growth strategy, and the provisional title reads ‘ERA 
NET COFUND on marine technologies’. The call 
text is very broad, but includes the application of 
biorefineries, and considering the statement that this 
topic is seeking synergies with the Joint 
Programming Initiative Healthy and Productive Seas 
and Oceans (JPI Oceans), the topic is worth attention 
also for ERA-MBT. 
Other types of partnerships of interest to ERA-MBT 
are also expected in the future, e.g. the Bio Based 
Industries Joint Undertaking, where projects closer to 
industrial application are being called for. 
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ERA-MBT 
IN A GLANCE 
 
 
Project Coordinator 
Steinar Bergseth 
The Research Council of Norway (RCN) 
+47 22037323 
 
ERA-MBT Partners 
The ERA-MBT partners welcome you to ERA-MBT and invite you to 
become involved in the shaping of a common ERA in Marine 
Biotechnology. Contact the individual project partners using the 
partner information page at the project website. 
 
Stay connected  
Subscribe to the newsletter mailing list 
Follow us on Twitter @ERA_MBT 
 
Contribute to 
The MarineBiotech wiki-pages which aggregate information on 
marine biotechnology to inform funding agencies, stakeholders and 
the interested public about developments, achievements and 
knowledge in this area.  
 
A LinkedIn communication forum to support exchanges between 
stakeholders and to highlight opportunities for interlinkage and 
collaboration. 
 
Comments? Suggestions?  
Please contact us at info@marinebiotech.eu. 
 
Upcoming events 
We are collecting information on all events related to the field of 
marine biotechnology.  
To stay up to date, please visit our upcoming events page. If you 
cannot find the event you are organising or attending and would like to 
have it featured in our events calendar, please contact us.  
 
 
 
